A main actor in pharmaceutical synthesis and specialty ingredients
A leader in pharmaceutical synthesis
Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.
Cross-functional knowledge in specialty ingredients
Seqens offers a wide continuum of technologies covering small-scale to large-scale chemical synthesis and distillation including distinctive reactions such as Fiedel-Craft, Grignard and low-metal capabilities. This industrial network is supported by focused R&D capabilities. Seqens offers high purity oxygenated solvents leveraging its back-integrationl and a large range of Minerals Specialties produced.Discover
A large expertise
Seqens has built a wide, comprehensive and cutting edge offer for the cosmetic market sourced in pharmaceutics and fine chemistry know-hows.Discover
A continuum of technologies
Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia.
More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.
Bicarbonate sodium used in dialysis
Seqens North America Named Best Pharmaceutical Synthesis Company 2019
Seqens to Unveil New Innovation and Development Center of Excellence
Seqens global presenceUse interactive map
Scientists, experts and engineers
Customers in more than 80 countries